Exact Mass: 488.1835

Exact Mass Matches: 488.1835

Found 203 metabolites which its exact mass value is equals to given mass value 488.1835, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp

beta-D-Glc-(1->4)-alpha-L-Rha-(1->3)-D-Glc; beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp

C18H32O15 (488.1741)

3-Fucosyllactose

(2S,3S,4R,5S,6S)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-6-methyloxane-3,4,5-triol

C18H32O15 (488.1741)

3-Fucosyllactose is a milk oligosaccharide isolated in 1958 (PMID: 13546862), and that was also isolated for the first time from the urine of a blood group O, nonsecretor, woman during pregnancy and lactation in 1977 (PMID: 838696). Is resistant to enzymic hydrolysis in the gastrointestinal tract of the infant; it is postulated that they reach the large intestine where they serve as substrates for bacterial metabolism. (PMID 10837303). 3-Fucosyllactose is a milk oligosaccharide isolated in 1958 (PMID: 13546862), and that was also isolated for the first time from the urine of a blood group O, nonsecretor, woman during pregnancy and lactation in 1977 (PMID: 838696)

2-Fucosyllactose

(2R,3R,4R,5R)-4-{[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,3,5,6-tetrahydroxyhexanal

C18H32O15 (488.1741)

2-Fucosyllactose (Fuc-a( 1->2)Galb(1->4)Glc) is an oligosaccharide first found in milk in the 1950s, and a well established isolation technique was found in 1972 (PMID: 5012321). It has been used as an acceptor substrate in assays of the blood group A and B gene specified glycosyltransferases since. (PMID 6894927). 2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk. 2'-Fucosyllactose regulates the expression of CD14, alleviates colitis and regulates the gut microbiome. 2'-Fucosyllactose stimulates T cells to increase IFN-γ production and decreases IL-6, IL-17, and TNF-α production of cytokines[1][2].

B-Trisaccharide

(2R,3S,4S)-4,5,6-trihydroxy-3-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexanal

C18H32O15 (488.1741)

B-Trisaccharide in blood group B is formed and excreated due to given Galactose. The B-trisaccharide is the only oligosaccharide detected in plasma after oral galactose administration to a blood-group-B secretor individual. The concentration was 0.38 mg/l of plasma.(PMID: 510288). B-Trisaccharide in blood group B is formed and excreated due to given Galactose.

Fucosyllactose

(2R,3S,4S,5S,6R)-2-{[(2S,3S,4S,5R,6R)-3,5-dihydroxy-2-methoxy-6-({[(2R,3S,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C18H32O15 (488.1741)

Fucosyllactose is an oligosaccharide in human milk that may serve as an anti-inflammatory component and might therefore contribute to the lower incidence of inflammatory diseases in human milk-fed infants. (PMID 15583750) [HMDB] Fucosyllactose is an oligosaccharide in human milk that may serve as an anti-inflammatory component and might therefore contribute to the lower incidence of inflammatory diseases in human milk-fed infants. (PMID 15583750).

Blood group B trisaccharide

2-{[2,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C18H32O15 (488.1741)

Israpafant

7-(2-chlorophenyl)-9,13-dimethyl-4-{2-[4-(2-methylpropyl)phenyl]ethyl}-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0²,⁶]trideca-2(6),4,7,10,12-pentaene

C28H29ClN4S (488.1801)

C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent

1-[O-beta-D-xylopyranosyl-(1->6)-O-beta-D-glucopyranosyl]-2,6-dimethoxy-4-propenyl-phenol

C22H32O12 (488.1894)

alpha-L-rhamnopyranosyl(1->4)-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranoside

C18H32O15 (488.1741)

2-methoxy-4-(2-propenyl)phenyl 6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside|beta-Gentobiosyl-eugenol|eugenyl beta-gentiobioside

C22H32O12 (488.1894)

beta-D-Mannopyranosyl-(1鈥樏傗垎4)-alpha-D-galactopyranosyl-(1鈥樏傗垎4)-L-rhamnose

C18H32O15 (488.1741)

SCHEMBL18612378

C18H32O15 (488.1741)

C22H32O12

C22H32O12 (488.1894)

(-)-(2R,3S)-1-(4-beta-D-glucopyranosyloxybenzyl) 4-methyl 2-isobutyltartrate|(-)-(2R,3S)-1-(4-beta-D-glucopyranosyloxybenzyl)-4-methyl-2-isobutyltartrate

C22H32O12 (488.1894)

Leucettamidine

C25H24N6O5 (488.1808)

SCHEMBL12195111

C18H32O15 (488.1741)

bromophycoic acid E

C27H37BrO3 (488.1926)

(3S,4S)-3-methyl-4-O-(6-O-galloyl)-beta-D-glucopyranosyloctanoic acid|(3S,4S)-4-beta-D-glucopyranosyloxy-3-methyloctanoic acid 6-O-gallate

C22H32O12 (488.1894)

callophycoic acid G

C27H37BrO3 (488.1926)

A monohydroxybenzoic acid that is 4-hydroxybenzoic acid substituted at position 3 by a decahydronaphthalen-1-ylmethyl group which in turn is substituted by a bromo, two methyl groups, a methylidene and a 4-methylpent-3-en-1-yl group at positions 6, 5, 8a, 2 and 5 respectively. A diterpenoid isolated from the Fijian red alga Callophycus serratus, it exhibits antibacterial, antimalarial and anticancer activities.

6-Deoxy-alpha-D-glucopyranosyl-(1?4)-D-glucose

C18H32O15 (488.1741)

acetyl barlerin

C22H32O12 (488.1894)

alphaalpha-D-Glucopyranosyl-(1?3)-beta-D-galactopyranosyl-(1?2)-L-rhamnose

C18H32O15 (488.1741)

SERICETIN DIACETATE

C29H28O7 (488.1835)

Ala His Met Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid